longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

LFMDP

LFMDP
----

LongbridgeAI

LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 8-K: FY2025 Q2 Revenue: USD 62.22 M

Earnings Watch
Aug 5, 2025 at 08:12 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Revenue: As of FY2025 Q2, the actual value is USD 62.22 M.

EPS: As of FY2025 Q2, the actual value is USD -0.06.

Segment Revenue

  • Total Revenue: Increased 23% year-over-year to $62.2 million, driven by a 30% increase in telehealth revenue.
  • Telehealth Revenue: Increased 30% to $48.6 million.
  • WorkSimpli Revenue: Increased 3% to $13.7 million.

Operational Metrics

  • Net Loss: GAAP net loss was $2.9 million or - $0.06 per share, compared to a net loss of $7.7 million or - $0.19 per share in the prior-year period.
  • Gross Margin: 88%, compared to 90% in the prior-year period due to revenue mix.
  • Adjusted EBITDA: Increased 223% to $7.1 million, compared to $2.2 million in the prior-year period.
  • Telehealth Adjusted EBITDA: Increased 560% to $3.4 million, compared to $0.5 million in the prior-year period.

Cash Flow

  • Operating Cash Flow: Generated more than $8 million of operating cash flow.
  • Cash Position: Exited the quarter with $36.2 million in cash, inclusive of paying down $2.1 million of senior debt during the quarter.

Unique Metrics

  • Active Telehealth Subscribers: Increased 16% to approximately 297,000 at quarter-end.

Outlook / Guidance

  • Third Quarter 2025 Guidance: Total revenue expected in the range of $61 million to $63 million, with telehealth revenue in the range of $48 million to $50 million.
  • Full Year 2025 Guidance: Total revenue expected in the range of $250 million to $255 million, revised from previous guidance of $268 million to $275 million.
  • Telehealth Adjusted EBITDA: Forecasted to be in the range of $14 million to $16 million, down from $21 million previously.

Login to unlock1,067characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

LifeMD Pref Share LFMDP 8.875 Perp 10/15/22

LifeMD Pref Share LFMDP 8.875 Perp 10/15/22

LFMDP.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--